Digestive & Intestinal Remedies (Pharmacies) - Denmark

  • Denmark
  • Revenue in the Digestives & Intestinal Remedies market is projected to reach US$3.13m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2028) of 1.79%, resulting in a market volume of US$3.36m by 2028.
  • In global comparison, most revenue will be generated in China (US$3,367.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.53 are generated in 2024.

Key regions: United States, South Korea, Japan, Canada, India

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Digestive & Intestinal Remedies (Pharmacies) market in Denmark has been experiencing steady growth in recent years, driven by several key factors.

Customer preferences:
In Denmark, there is a growing trend towards natural and holistic remedies for digestive and intestinal issues. Many consumers are seeking out products that are made from organic ingredients and free from artificial additives. This shift in consumer preferences is driving the demand for natural digestive and intestinal remedies in the market.

Trends in the market:
One of the major trends in the Digestive & Intestinal Remedies market in Denmark is the increasing popularity of probiotics. Probiotics are live bacteria and yeasts that are beneficial for digestive health. They are commonly found in yogurt, fermented foods, and dietary supplements. The demand for probiotic products has been rising as consumers become more aware of the importance of maintaining a healthy gut microbiome. This trend is expected to continue driving the growth of the market. Another trend in the market is the rising prevalence of digestive disorders such as irritable bowel syndrome (IBS) and acid reflux. These conditions affect a significant portion of the population and create a demand for effective remedies. As a result, there is a growing market for over-the-counter medications and natural remedies that can alleviate the symptoms of these digestive disorders.

Local special circumstances:
Denmark has a well-developed healthcare system and a high level of health consciousness among its population. The government provides universal healthcare coverage, which ensures that individuals have access to necessary medical treatments. This healthcare system contributes to the demand for digestive and intestinal remedies, as individuals seek solutions for their digestive health issues.

Underlying macroeconomic factors:
The Danish economy has been relatively stable in recent years, with a high GDP per capita and low unemployment rates. This economic stability provides consumers with the financial means to purchase healthcare products, including digestive and intestinal remedies. Additionally, the aging population in Denmark is also contributing to the growth of the market, as older individuals are more likely to experience digestive issues and seek remedies for them. In conclusion, the Digestive & Intestinal Remedies (Pharmacies) market in Denmark is developing due to changing customer preferences towards natural remedies, the increasing popularity of probiotics, the rising prevalence of digestive disorders, the well-developed healthcare system, and the stable macroeconomic factors in the country.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)